Biography and Research Information

OverviewAI-generated summary

Carson W. Ercanbrack's research has focused on various areas within health sciences, including microbial genetics, clinical case reports, and treatment efficacy. His work on bacterial genetics includes a genome-wide screening of oxidizing agent resistance genes in Escherichia coli. In clinical settings, Ercanbrack has contributed to case series and reports on conditions such as retinal capillary hemangioblastoma regression induced by belzutifan, the utility of pan-bacterial and pan-fungal PCR in endophthalmitis, and early optical coherence tomography signs of erdafitinib-induced retinopathy. He has also investigated maculopathy in patients with diabetes and unusual pediatric red eye presentations. Further clinical contributions include updates on periocular post-Mohs reconstructive surgery. Ercanbrack has also been involved in phase 3 clinical trials, such as the Total Therapy (TT)-4 trial for multiple myeloma. His scholarship is reflected in a h-index of 2 and 9 total publications.

Metrics

  • h-index: 2
  • Publications: 9
  • Citations: 42

Selected Publications

  • Updates on periocular post-Mohs reconstructive surgery: a clinical practice review (2025) DOI
  • Early Optical Coherence Tomography Signs of Erdafitinib-Induced Retinopathy (2024) DOI
  • Utility of pan-bacterial and pan-fungal PCR in endophthalmitis: case report and review of the literature (2024) DOI
  • Maculopathy in a 52-Year-Old Patient With Diabetes (2024) DOI
  • Belzutifan-induced regression of retinal capillary hemangioblastoma: A case-series (2024) DOI
  • Unusual Pediatric Red Eye (2024) DOI
  • Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma (2023) DOI
  • Genome-Wide Screening of Oxidizing Agent Resistance Genes in Escherichia coli (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics